Αποτελέσματα Αναζήτησης
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
28 Αυγ 2023 · Adverse Effects. The most common adverse effects of ezetimibe include headache, runny nose, and sore throat. Less common reactions include body aches, back pain, chest pain, diarrhea, joint pain, fatigue, and weakness. There have been reports of rhabdomyolysis in combination with statin therapy and, rarely, with monotherapy.
4 Μαΐ 2022 · Moderate to high certainty evidence shows that ezetimibe has little to no effect on adverse events (compared with no ezetimibe), including cancer, new-onset diabetes, neurocognitive events, fractures, myalgia or muscular pain leading to discontinuation, or discontinuation due to gastrointestinal adverse events or any adverse events.
Results: Compelling evidence from the majority of the data reviewed here showed that adverse effects associated with ezetimibe use are few and mild without having been associated with serious clinical outcomes.
5 Ιουλ 2024 · Get emergency medical help right away if you have signs of an allergic reaction to ezetimibe: hives (raised, itchy red rash, sometimes with target-shaped lesions); difficulty breathing or swallowing, wheezing, chest tightness, swelling of your face, lips, tongue, or throat, or anywhere on your body.
Myopathy is more common when high doses of simvastatin (80 milligrams) with ezetimibe (10 mg) are used, but some people get myopathy with lower doses. Check with your doctor right away if you have dark-colored urine, diarrhea, a fever, muscle cramps or spasms, muscle pain or stiffness, or feel very tired or weak.
18 Δεκ 2007 · Results: Compelling evidence from the majority of the data reviewed here showed that adverse effects associated with ezetimibe use are few and mild without having been associated with serious clinical outcomes. In most studies ezetimibe has not been associated with increased rates of myopathy or rhabdomyolysis, whether used alone or in ...
